April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Chris Boerner: The FDA approved our new subcutaneous immunotherapy treatment
Dec 28, 2024, 15:55

Chris Boerner: The FDA approved our new subcutaneous immunotherapy treatment

Chris Boerner, Board Chair and Chief Executive Officer at Bristol Myers Squibb, posted on LinkedIn:

“Today, the FDA approved our new subcutaneous immunotherapy treatment that offers a patient-centric experience. This is remarkable work that can positively impact the lives of patients with certain types of cancer. Congratulations to my colleagues across Bristol Myers Squibb whose relentless pursuit of bold science contributed to this achievement. Looking forward, we will continue to set the bar even higher because, together, we are defining what’s possible for the future of science and the patients we serve.

Learn more.”